Evidence map›Paper›PMID 27077475›Full record

ArticleBioconjugate chemistry2016

Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells.

Amy M Wen, Karin L Lee, Pengfei Cao, Katrina Pangilinan, Bradley L Carpenter, Patricia Lam, Frank A Veliz, Reza A Ghiladi, Rigoberto C Advincula, Nicole F Steinmetz

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Viral Nanoparticle System: An Effective Platform for Photodynamic Therapy.International journal of molecular sciences · 2021
    Review
  10. Solid-Phase Synthesis of Megamolecules.Journal of the American Chemical Society · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Nanomedicine Strategies to Target Tumor-Associated Macrophages.International journal of molecular sciences · 2017
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Amy M Wen
Karin L Lee
Pengfei Cao
Katrina Pangilinan
Bradley L CarpenterDepartment of Chemistry, North Carolina State University , Raleigh, North Carolina 27695, United States.
Patricia Lam
Frank A Veliz
Reza A GhiladiDepartment of Chemistry, North Carolina State University , Raleigh, North Carolina 27695, United States.
Rigoberto C Advincula
Nicole F Steinmetz
North Carolina State University · US

Funding

Interdisciplinary Biomedical Imaging Training ProgramT32EB007509 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI DAVID Lynn WILSON, Xin Yu · 2007 to 2026
$5.6M
Hemostasis-Independent targeted treatment of thrombosisF31HL129703 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI WEN, AMY · 2015 to 2015
$13k
NHLBI NIH HHS F31 HL129703NIBIB NIH HHS T32 EB007509
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a promising avenue for greater treatment efficacy of highly resistant and aggressive melanoma. Through photosensitizer attachment to nanoparticles, specificity of delivery can be conferred to further reduce potential side effects. While the main focus of PDT is the destruction of cancer cells, additional targeting of tumor-associated macrophages also present in the tumor microenvironment could further enhance treatment by eliminating their role in processes such as invasion, metastasis, and immunosuppression. In this study, we investigated PDT of macrophages and tumor cells through delivery using the natural noninfectious nanoparticle cowpea mosaic virus (CPMV), which has been shown to have specificity for the immunosuppressive subpopulation of macrophages and also targets cancer cells. We further explored conjugation of CPMV/dendron hybrids in order to improve the drug loading capacity of the nanocarrier. Overall, we demonstrated effective elimination of both macrophage and tumor cells at low micromolar concentrations of the photosensitizer when delivered with the CPMV bioconjugate, thereby potentially improving melanoma treatment.

Indexed as

PhotochemotherapyAnimalsComovirusDendrimersDrug CarriersMacrophagesMelanoma, ExperimentalMiceNanoparticlesPhotosensitizing AgentsRAW 264.7 CellsDendrimersDrug CarriersPhotosensitizing Agents

Identifiers

PMID27077475
PMCPMC5160013
OpenAlexW2338221794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.